| Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ... Gut 66 (2), 342-351, 2017 | 416 | 2017 |
| Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ... Gut 61 (3), 427-438, 2012 | 370 | 2012 |
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ... Journal of hepatology 52 (3), 370-379, 2010 | 297 | 2010 |
| Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control M Hong, AL Puaux, C Huang, L Loumagne, C Tow, C Mackay, M Kato, ... Cancer research 71 (22), 6997-7009, 2011 | 267 | 2011 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 231 | 2021 |
| Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma A Nardin, ML Lefebvre, K Labroquere, O Faure, JP Abastado Current cancer drug targets 6 (2), 123-133, 2006 | 170 | 2006 |
| Allergic airway diseases in a tropical urban environment are driven by dominant mono‐specific sensitization against house dust mites AK Andiappan, KJ Puan, B Lee, A Nardin, M Poidinger, J Connolly, ... Allergy 69 (4), 501-509, 2014 | 152 | 2014 |
| Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of … ML Lefebvre, SW Krause, M Salcedo, A Nardin Journal of immunotherapy 29 (4), 388-397, 2006 | 146 | 2006 |
| Methods for the prevention and treatment of cancer using anti-C3b (i) antibodies R Taylor, A Nardin, WM Sutherland, MH Sokoloff, L Chung US Patent 6,572,856, 2003 | 125 | 2003 |
| CC chemokine ligand 19 secreted by mature dendritic cells increases naive T cell scanning behavior and their response to rare cognate antigen A Kaiser, E Donnadieu, JP Abastado, A Trautmann, A Nardin The Journal of Immunology 175 (4), 2349-2356, 2005 | 121 | 2005 |
| Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages R Romieu-Mourez, M Solis, A Nardin, D Goubau, V Baron-Bodo, R Lin, ... Cancer research 66 (21), 10576-10585, 2006 | 117 | 2006 |
| Hepatocellular carcinoma cells up-regulate PVRL1, stabilizing PVR and inhibiting the cytotoxic T-cell response via TIGIT to mediate tumor resistance to PD1 inhibitors in mice DKC Chiu, VWH Yuen, JWS Cheu, LL Wei, V Ting, M Fehlings, ... Gastroenterology 159 (2), 609-623, 2020 | 116 | 2020 |
| Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency L Warter, CY Lee, R Thiagarajan, M Grandadam, S Lebecque, RTP Lin, ... The Journal of Immunology 186 (5), 3258-3264, 2011 | 115 | 2011 |
| Macrophages and cancer A Nardin, JP Abastado Front Biosci 13 (3), 494-505, 2008 | 108 | 2008 |
| Use of human monoclonal antibodies to treat Chikungunya virus infection J Fric, S Bertin-Maghit, CI Wang, A Nardin, L Warter The Journal of infectious diseases 207 (2), 319-322, 2013 | 103 | 2013 |
| Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8+ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals AD Redd, A Nardin, H Kared, EM Bloch, B Abel, A Pekosz, ... Mbio 13 (2), e03617-21, 2022 | 101 | 2022 |
| CD8+ T-cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants AD Redd, A Nardin, H Kared, EM Bloch, A Pekosz, O Laeyendecker, ... Open Forum Infectious Diseases 8 (7), ofab143, 2021 | 101 | 2021 |
| Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients V Chew, C Tow, C Huang, E Bard-Chapeau, NG Copeland, NA Jenkins, ... JNCI: Journal of the National Cancer Institute 104 (23), 1796-1807, 2012 | 99 | 2012 |
| How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? A Nardin, MA Lindorfer, RP Taylor Molecular Immunology 36 (13-14), 827-835, 1999 | 85 | 1999 |
| Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment M Fehlings, S Jhunjhunwala, M Kowanetz, WE O’Gorman, PS Hegde, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 70 | 2019 |
